Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Roberta M. Tankanow"'
Autor:
Rivka Siden, Burgunda V. Sweet, Helen R. Tamer, Todd D. Benner, Roberta M. Tankanow, Scott R. McCreadie, Michael E. McGregory
Publikováno v:
American Journal of Health-System Pharmacy. 65:969-973
Purpose. The development of a computerized system for protocol management, dispensing, inventory accountability, and billing by the investigational drug service (IDS) of a university health system is described. Summary. After an unsuccessful search f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::609cec628459be5fc3b6232b84b76fea
https://doi.org/10.2146/ajhp070212
https://doi.org/10.2146/ajhp070212
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 9:110-116
OBJECTIVES Patients are assuming responsibility for their own health by self-medicating with dietary supplements, often without physician knowledge or oversight. The objectives of this study were to determine: 1) pediatric dietary supplement use by s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d25e264d6ad93aca23f8b55e7bc6b97
https://doi.org/10.5863/1551-6776-9.2.110
https://doi.org/10.5863/1551-6776-9.2.110
Autor:
Thomas M. Annesley, Scott G. Smith, Barry E. Bleske, Janice L. Welton, Daniel S Streetman, Helen R. Tamer, Keith D. Aaronson, Roberta M. Tankanow
Publikováno v:
The Journal of Clinical Pharmacology. 43:637-642
Hawthorn, an herbal supplement, is currently being evaluated for the treatment of heart failure. The flavonoid components of hawthorn may be responsible for hawthorn's beneficial effects in the treatment of heart failure. However, these components ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e28f6b084994e627ff5b8b61ca4b7a2
https://doi.org/10.1177/0091270003253417
https://doi.org/10.1177/0091270003253417
Autor:
Sommer A. Wrona, Roberta M. Tankanow
Publikováno v:
American Journal of Health-System Pharmacy. 51:347-353
The pathophysiology of alcoholic hepatitis and the use of corticosteroids in the management of alcoholic hepatitis are described. Alcoholic hepatitis is a chronic, progressive, often fatal disease. Symptoms may be absent or may range from mild to sev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96934611cac24cac602264bd93603582
https://doi.org/10.1093/ajhp/51.3.347
https://doi.org/10.1093/ajhp/51.3.347
Autor:
Betty J. Chaffee, Roberta M. Tankanow
Publikováno v:
American Journal of Health-System Pharmacy. 48:1593-1609
The chemistry, pharmacokinetics, adverse effects, stability, compatibility, and dosage of ondansetron hydrochloride are described, and clinical studies of the use of ondansetron for the prophylaxis of nausea and vomiting induced by antineoplastic the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86004fabfb0a4ad9ce469291e9d85327
https://doi.org/10.1093/ajhp/48.7.1593
https://doi.org/10.1093/ajhp/48.7.1593
Autor:
Roberta M. Tankanow, Vilma Yuzbasiyan-Gurkin, George J. Brewer, Robert D. Dick, Anne B. Young, Karen J. Kluin
Publikováno v:
Archives of Neurology. 48:42-47
Patients with Wilson's disease who present with acute neurological symptoms often become clinically worse when initially treated with penicillamine. Other available anticopper drug therapies do not appear to offer a solution to this treatment problem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9afc742a709b2e21339f3caee43e855a
https://doi.org/10.1001/archneur.1991.00530130050019
https://doi.org/10.1001/archneur.1991.00530130050019
Autor:
Matthew T. Lorincz, Michael L. Schilsky, Roberta M. Tankanow, Paolo Moretti, Peter Hedera, George J. Brewer, Karen J. Kluin, John K. Fink, Martha D. Carlson, Robert B. Dick, Julia Sitterly, Frederick K. Askari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5611c33914998a4875e449e93b4c25fd
https://doi.org/10.1017/cbo9780511666971.010
https://doi.org/10.1017/cbo9780511666971.010
Autor:
William F. Chandler, R.F. Diaz, Allen S. Lichter, Terry W. Hood, Harry S. Greenberg, Roberta M. Tankanow, Stephen S. Gebarski, William D. Ensminger, Larry Junck, T.J. Hegarty, Michaelyn A. Page, Paul E. McKeever, Phillip L. Stetson, Allan F. Thornton
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 19:421-428
In the 1950's it was first observed that mammalian cells exposed to the halogenated deoxyuridines were more sensitive to ultraviolet light and radiation than untreated cells. This prompted early clinical trials with bromodeoxyuridine (BUdR) which sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f92528057d8d9a503de9d95b39654e5c
https://doi.org/10.1016/0360-3016(90)90552-u
https://doi.org/10.1016/0360-3016(90)90552-u
Autor:
Peter Hedera, Frederick K. Askari, Robert B. Dick, George J. Brewer, Martha D. Carlson, Michael L. Schilsky, Karen J. Kluin, Paolo Moretti, Julia Sitterly, John K. Fink, Roberta M. Tankanow, Matthew T. Lorincz
Publikováno v:
Progress in Neurotherapeutics and Neuropsychopharmacology. 3
Background: The initial treatment of the neurologic presentation of Wilson's disease is problematic. Penicillamine, used for years on most patients, causes neurologic worsening in up to half of such patients, and half of those who worsen never recove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::142751cded5daaf73daf88e3139ec4f4
https://doi.org/10.1017/s1748232107000043
https://doi.org/10.1017/s1748232107000043
Publikováno v:
American Journal of Health-System Pharmacy. 49:633-635
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc64c56c6d8978d968b882c6232b19fc
https://doi.org/10.1093/ajhp/49.3.633
https://doi.org/10.1093/ajhp/49.3.633